Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor-ligand binding sites and virtual screening.

Channa K Hattotuwagama1, Matthew N Davies, Darren R Flower

  • 1The Jenner Institute, University of Oxford, Compton, Berkshire RG20 7NN, UK.

Current Medicinal Chemistry
|May 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracting prime protein targets as possible drug candidates: machine learning evaluation.

Medical & biological engineering & computing·2023
Same author

Towards Effective Consensus Scoring in Structure-Based Virtual Screening.

Interdisciplinary sciences, computational life sciences·2022
Same author

To Affinity and Beyond: A Personal Reflection on the Design and Discovery of Drugs.

Molecules (Basel, Switzerland)·2022
Same author

West Nile Virus Vaccine Design by T Cell Epitope Selection: <i>In Silico</i> Analysis of Conservation, Functional Cross-Reactivity with the Human Genome, and Population Coverage.

Journal of immunology research·2020
Same author

Correction to: Computational assembly of a human Cytomegalovirus vaccine upon experimental epitope legacy.

BMC bioinformatics·2020
Same author

Drug Discovery: Today and Tomorrow.

Bioinformation·2020

Drug discovery drives pharmaceutical profitability. Modern approaches integrate medicinal chemistry, structural biology, and computational chemistry to understand drug-target interactions for developing effective medicines.

Area of Science:

  • Pharmaceutical Science
  • Medicinal Chemistry
  • Structural Biology
  • Computational Chemistry

Background:

  • Drug discovery is crucial for pharmaceutical industry profitability, requiring novel, safe, efficacious, and cost-effective drugs.
  • Historically empirical, drug discovery is now guided by understanding disease mechanisms at the receptor level and drug-molecule interactions within the physiome.

Purpose of the Study:

  • To explore the integration of medicinal chemistry, structural biology, and computational chemistry in modern drug discovery.
  • To highlight how understanding ligand-binding site interactions facilitates the drug development process.

Main Methods:

  • Review of established principles in medicinal chemistry regarding ligand-binding site relationships.
  • Application of structural molecular biology to elucidate binding site characteristics.

Related Experiment Videos

  • Utilization of computational chemistry to analyze and predict ligand-binding interactions.

    • Main Results:

    • Medicinal chemistry and structural biology offer complementary perspectives on ligand-binding site dynamics.
    • Integrated approaches enable a deeper understanding of the requirements for effective drug molecules.
    • Computational chemistry aids in elucidating specific binding site-ligand interactions.

    Conclusions:

    • The synergy between medicinal chemistry, structural biology, and computational chemistry significantly advances drug discovery.
    • Elucidating binding site-ligand interactions is key to developing marketable pharmaceuticals.
    • This integrated strategy enhances both conceptual and pragmatic aspects of the drug discovery pipeline.